Takeda Pharmaceutical Company Limited, a leading pharmaceutical company headquartered in Tokyo, Japan, operates globally with a focus on research, development, manufacturing, marketing, and out-licensing of pharmaceutical products. The company's products range from gastroenterology to rare diseases, plasma-derived therapies, oncology, and neuroscience, with leading brands such as Entyvio, Alofisel, and Vyvansese. Takeda has entered into collaboration, licensing, and strategic alliance agreements with numerous leading pharmaceutical companies, research institutions, and biotech firms. These include Neurocrine Biosciences, Inc., the University of Texas MD Anderson Cancer Center, and Egle Therapeutics SAS among others. The company was founded in 1781 and continues to expand its global presence with operations in the United States, Europe, Canada, Latin America, Russia, and Asia.
Takeda Pharmaceutical Company's ticker is TAK
The company's shares trade on the NYSE stock exchange
They are based in Tokyo, Japan
There are 10,000+ employees working at Takeda Pharmaceutical Company
It is https://www.takeda.com/
Takeda Pharmaceutical Company is in the Healthcare sector
Takeda Pharmaceutical Company is in the Drug Manufacturers - Other industry
The following five companies are Takeda Pharmaceutical Company's industry peers:
- Regenerx Biopharmaceuticals Inc.